Literature DB >> 16207699

Adherence to nutrition supplements among patients with a fall-related lower limb fracture.

Michelle D Miller1, Lynne A Daniels, Elaine Bannerman, Maria Crotty.   

Abstract

BACKGROUND: The purpose of this study was to provide a detailed evaluation of adherence to nutrition supplements by patients with a lower limb fracture.
METHODS: These descriptive data are from 49 nutritionally "at-risk" patients aged 70+ years admitted to the hospital after a fall-related lower limb fracture and allocated to receive supplementation as part of a randomized, controlled trial. Supplementation commenced on day 7 and continued for 42 days. Prescribed volumes aimed to meet 45% of individually estimated theoretical energy requirements to meet the shortfall between literature estimates of energy intake and requirements. The supplement was administered by nursing staff on medication rounds in the acute or residential care settings and supervised through thrice-weekly home visits postdischarge.
RESULTS: Median daily percent of the prescribed volume of nutrition supplement consumed averaged over the 42 days was 67% (interquartile range [IQR], 31-89, n = 49). There was no difference in adherence for gender, accommodation, cognition, or whether the supplement was self-administered or supervised. Twenty-three participants took some supplement every day, and a further 12 missed <5 days. For these 35 "nonrefusers," adherence was 82% (IQR, 65-93), and they lost on average 0.7% (SD, 4.0%) of baseline weight over the 6 weeks of supplementation compared with a loss of 5.5% (SD, 5.4%) in the "refusers" (n = 14, 29%), p = .003.
CONCLUSIONS: We achieved better volume and energy consumption than previous studies of hip fracture patients but still failed to meet target supplement volumes prescribed to meet 45% of theoretical energy requirements. Clinicians should consider alternative methods of feeding such as a nasogastric tube, particularly in those patients where adherence to oral nutrition supplements is poor and dietary intake alone is insufficient to meet estimated energy requirements.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16207699     DOI: 10.1177/0115426505020005569

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  6 in total

Review 1.  Nutritional supplementation for hip fracture aftercare in older people.

Authors:  Alison Avenell; Toby O Smith; James P Curtain; Jenson Cs Mak; Phyo K Myint
Journal:  Cochrane Database Syst Rev       Date:  2016-11-30

2.  Automatic extraction and assessment of lifestyle exposures for Alzheimer's disease using natural language processing.

Authors:  Xin Zhou; Yanshan Wang; Sunghwan Sohn; Terry M Therneau; Hongfang Liu; David S Knopman
Journal:  Int J Med Inform       Date:  2019-08-06       Impact factor: 4.046

Review 3.  Protein and energy supplementation in elderly people at risk from malnutrition.

Authors:  Anne C Milne; Jan Potter; Angela Vivanti; Alison Avenell
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

4.  Effectiveness of oral nutritional supplementation for older women after a fracture: rationale, design and study of the feasibility of a randomized controlled study.

Authors:  Ian D Cameron; Susan E Kurrle; Cesar Uy; Keri A Lockwood; Lydia Au; Frederieke G Schaafsma
Journal:  BMC Geriatr       Date:  2011-06-10       Impact factor: 3.921

5.  Study protocol: follow-up home visits with nutrition: a randomised controlled trial.

Authors:  Anne Marie Beck; Stine Kjær; Birthe S Hansen; Rikke L Storm; Kirsten Thal-Jantzen
Journal:  BMC Geriatr       Date:  2011-12-28       Impact factor: 3.921

6.  Effects of protein-rich nutritional supplementation and bisphosphonates on body composition, handgrip strength and health-related quality of life after hip fracture: a 12-month randomized controlled study.

Authors:  Lena Flodin; Tommy Cederholm; Maria Sääf; Eva Samnegård; Wilhelmina Ekström; Amer N Al-Ani; Margareta Hedström
Journal:  BMC Geriatr       Date:  2015-11-17       Impact factor: 3.921

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.